David C. Myles's Insider Trades & SAST Disclosures
David C. Myles's most recent trade in Olema Pharmaceuticals Inc was a trade of 205,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David C. Myles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 48,750 | 624,399 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 13,314 | 598,633 | - | 8.7 | 115,299 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 9.38 per share. | 09 Dec 2024 | 12,452 | 611,947 | - | 9.4 | 116,800 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 300 | 598,333 | - | 9.4 | 2,817 | Common Stock |
| Olema Pharmaceuticals Inc | C. David Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 26,250 | 587,728 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 14.87 per share. | 20 Nov 2023 | 6,776 | 580,952 | - | 14.9 | 100,759 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 20 Nov 2023 | 6,653 | 574,099 | - | 13.9 | 92,410 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.32 per share. | 20 Nov 2023 | 200 | 580,752 | - | 15.3 | 3,064 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 17.61 per share. | 08 Nov 2023 | 200 | 561,270 | - | 17.6 | 3,522 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 01 Nov 2023 | 6,668 | 565,343 | - | 15.0 | 100,153 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 01 Nov 2023 | 3,332 | 562,011 | - | 15.4 | 51,180 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 01 Nov 2023 | 541 | 561,470 | - | 17.5 | 9,473 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 19 Sep 2023 | 20,000 | 572,011 | - | 12.7 | 253,400 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | David C. Myles | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 118,750 | 118,750 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | David C. Myles | CHIEF DEVELOPMENT OFFICER | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 10 Dec 2021 | 10,000 | 582,901 | - | 10.3 | 103,000 | Common Stock |
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | 23 Nov 2020 | 154,846 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | 23 Nov 2020 | 154,846 | 154,846 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | 23 Nov 2020 | 12,831 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | 23 Nov 2020 | 12,831 | 12,831 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 179,340 | 179,340 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | David C. Myles | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 143,472 | 591,821 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges